Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000936392-08-000273
Filing Date
2008-04-17
Accepted
2008-04-16 18:56:16
Documents
3
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT #1 a38914a1e10vkza.htm 10-K/A 15072
2 EXHIBIT 31.1 a38914a1exv31w1.htm EX-31.1 5953
3 EXHIBIT 31.2 a38914a1exv31w2.htm EX-31.2 6019
  Complete submission text file 0000936392-08-000273.txt   28457
Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Filer) CIK: 0001333248 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33103 | Film No.: 08760726
SIC: 2834 Pharmaceutical Preparations